Role of MSCT of Chest in Differentiation Between COPD Patients According to Their Smoking Status
Role of Multislice Computed Tomography (MSCT) Chest in Differentiation Between Chronic Obstructive Pulmonary Disease(COPD) Patients According to Their Smoking Status
1 other identifier
observational
90
0 countries
N/A
Brief Summary
Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality all over the world. Smoking is considered as an important risk factor, but other risk factors are present. Around 30 % of patients with COPD are non-smokers. Cessation of smoking in patients with COPD causes decreases the presence of micronodules and other criteria of CT chest. In last few years, some researchers reported that cessation of smoking raise the apparent extent of emphysema. The cause is not obvious, but this paradoxical fall in lung density is thaught to be resulting from decrease in inflammation after smoking cessation. CT chest criteria of COPD in active smokers, non-smokers and ex-smokers seem to be different. So, comparison between CT chest Criteria of COPD in smokers, ex-smokers and non-smokers will be searched in this study to detect the role of multislice computed tomography (MSCT) chest in differentiation between COPD patients according to their smoking status.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2022
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 28, 2022
CompletedFirst Posted
Study publicly available on registry
July 27, 2022
CompletedStudy Start
First participant enrolled
August 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2023
CompletedAugust 2, 2022
August 1, 2022
8 months
June 28, 2022
August 1, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Number of participants with criteria of severe COPD
Criteria of severe COPD include emphysematous bullae, thick bronchial walls.
18 months
Study Arms (3)
First Group
Thirty patients of COPD smokers patients.
Second group
Thirty patients of COPD ex-smokers patients.
Third group
Thirty patients of COPD non-smokers patients.
Interventions
Multi slice Computed Tomography of the chest
Eligibility Criteria
COPD patients either smokers, ex-smokers or non-smokers
You may qualify if:
- All patients with chronic obstructive Pulmonary Disease.
- Patients above 18 years.
You may not qualify if:
- Patients with unclear smoking history.
- Patients with active pneumonia.
- Patients with acute COPD exacerbation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Somaia Ahmad AbdAllah Ahmad, M.B.B.Ch
Assiut University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Main investigator
Study Record Dates
First Submitted
June 28, 2022
First Posted
July 27, 2022
Study Start
August 1, 2022
Primary Completion
April 1, 2023
Study Completion
July 1, 2023
Last Updated
August 2, 2022
Record last verified: 2022-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- 2 years
- Access Criteria
- Medical researchers
COPD MSCT criteria smoking status